Free Trial
NASDAQ:SBFM

Sunshine Biopharma 11/5/2024 Earnings Report

Sunshine Biopharma logo
$1.26 -0.05 (-3.44%)
As of 02:12 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Sunshine Biopharma EPS Results

Actual EPS
-$0.94
Consensus EPS
$9.00
Beat/Miss
Missed by -$9.94
One Year Ago EPS
N/A

Sunshine Biopharma Revenue Results

Actual Revenue
$8.44 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Sunshine Biopharma Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Sunshine Biopharma's next earnings date is estimated for Monday, May 19, 2025, based on past reporting schedules.

Conference Call Resources

Sunshine Biopharma Earnings Headlines

Sunshine Biopharma launches Everolimus in Canada
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
See More Sunshine Biopharma Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sunshine Biopharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sunshine Biopharma and other key companies, straight to your email.

About Sunshine Biopharma

Sunshine Biopharma (NASDAQ:SBFM), a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is headquartered in New York, New York.

View Sunshine Biopharma Profile

More Earnings Resources from MarketBeat